(Q46845118)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18087163%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

title

Basophil histamine release decreases during omalizumab therapy in allergic asthmatics (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18087163%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

0 references

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18087163%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

author name string

Oliver Noga

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18087163%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

Gerald Hanf

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18087163%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

Gert Kunkel

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18087163%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

publication date

14 December 2007

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18087163%20AND%20SRC:MED&resulttype=core&format=json

International Archives of Allergy and Immunology

29 December 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18087163%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

volume

146

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18087163%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18087163%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

page(s)

66-70

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18087163%20AND%20SRC:MED&resulttype=core&format=json

Omalizumab rapidly decreases nasal allergic response and FcepsilonRI on basophils.

29 December 2019

cites work

1 reference

Effect of omalizumab treatment on peripheral eosinophil and T-lymphocyte function in patients with allergic asthma.

21 January 2018

1 reference

Effects of treatment with anti-immunoglobulin E antibody omalizumab on airway inflammation in allergic asthma

21 January 2018

1 reference

Omalizumab provides long-term control in patients with moderate-to-severe allergic asthma

21 January 2018

1 reference

The anti-IgE antibody omalizumab improves asthma-related quality of life in patients with allergic asthma

21 January 2018

1 reference

Omalizumab, a recombinant humanized anti-IgE antibody, reduces asthma-related emergency room visits and hospitalizations in patients with allergic asthma.

21 January 2018

1 reference

Immunological and clinical changes in allergic asthmatics following treatment with omalizumab

21 January 2018

1 reference

Diagnostic tests based on human basophils: potentials, pitfalls and perspectives.

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1159/000112504

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18087163%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

1 reference